Medindia
Medindia LOGIN REGISTER
Advertisement

Angiotech to participate in Credit Suisse Global Leveraged Finance Conference

Friday, March 21, 2008 General News
Advertisement
VANCOUVER, March 20 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medicaldevice company, is scheduled to participate in the Credit Suisse GlobalLeveraged Finance Conference, which is being held March 24-27 in Phoenix,Arizona.
Advertisement

Mr. Thomas Bailey, Angiotech's Chief Financial Officer, is scheduled topresent on Wednesday, March 26, beginning at approximately 8:00 am MountainTime. A question and answer session will immediately follow the presentation.
Advertisement

Presentations at this conference will not be webcast. More information isavailable on the Angiotech website (www.angiotech.com) under the Investorssection.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical andmedical device company with over 1,500 dedicated employees. Angiotechdiscovers, develops and markets innovative treatment solutions for diseases orcomplications associated with medical device implants, surgical interventionsand acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP),please visit our website at www.angiotech.com.

CONTACT: Deirdre Neary, Manager, Investor Relations, AngiotechPharmaceuticals, Inc., (604) 222-7056, [email protected]

SOURCE Angiotech Pharmaceuticals, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close